To address this hypothesis, we silenced CLSPN expression by siRNA and evaluated cell survival and apoptosis in UROtsa (benign) and 5637 (urothelial carcinoma) cells (Figure 3E). This evidence concerns the gene CLSPN and urothelial carcinoma.